Reed Tech
LexisNexis Reed Tech provides regulatory data management and submission services for medical devices and drug products, including SPL, eCTD, and UDI data handling for the FDA.
Reed Tech, part of LexisNexis, provides regulatory solutions and data management services for medical devices and drug products. The company works with Life Sciences professionals across pharmaceuticals, medical devices and regulatory affairs, handling the collection, transformation, submission and analysis of regulatory data for clients ranging from small producers to the world's largest global manufacturers. Its services are used by seven of the top ten pharmaceutical providers worldwide.
Its technical work centres on regulatory data management and submission formats. The company's Structured Product Labeling (SPL) services support US FDA product listings; it reports more than 15 years of SPL experience and a 99.95% on-time delivery rate. In medical device Unique Device Identification (UDI), Reed Tech manages product data for global health authorities, including submissions to the FDA Global UDI Database (GUDID), where it says it handles 34% of electronic records filed annually and has submitted more than 750,000 records. The company also provides eCTD submission services for pharmaceutical filings, drug listing and establishment registration with the US FDA, and US Agent representation.
Beyond individual services, Reed Tech offers end-to-end regulatory data solutions covering the full lifecycle from collection to analytics. The company operates in the United States and globally, serving the pharmaceutical, medical device and drug product sectors.